Online citations, reference lists, and bibliographies.
← Back to Search

Final Survival And Safety Results For 21,064 Non-small-cell Lung Cancer (NSCLC) Patients Who Received Compassionate Use Gefitinib In A U.S. Expanded Access Program (EAP)

J. Ochs, J. J. Grous, K. L. Warner

Save to my Library
Download PDF
Analyze on Scholarcy
Share